Compare Amphastar Pharmaceuticals Inc (AMPH) vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF (VTIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF — how do they compare? Amphastar Pharmaceuticals Inc trades at $19.38 (market cap $826.08M), while Vanguard Sht-Term Inflation-Protected Sec Idx ETF trades at $49.62. Which is the better fit depends on your goals.
| AMPH | VTIP | |
|---|---|---|
Market Cap | $826.08M | — |
Sector | Health | — |
52-Week High | $30.81 | $50.75 |
52-Week Low | $16.87 | $49.39 |
Enterprise Value | $1.22B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
VTIP trades at $49.64, showing minimal daily movement with a slight decline of -0.04%. The ETF maintains a bullish technical signal overall, supported by oscillator readings, though moving averages indicate short-term bearish pressure. Recent institutional activity shows significant position increases by multiple financial firms, reflecting confidence in the inflation-protected bond strategy amid persistent inflation concerns.
As a short-term inflation-protected securities ETF, VTIP offers protection against rising costs with projected returns of 3.8% at current inflation rates. Key risks include interest rate sensitivity and Fed policy uncertainty, but institutional accumulation and inflation hedging demand provide support for defensive portfolio positioning.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Vanguard Sht-Term Inflation-Protected Sec Idx ETF
The index is a market-capitalization-weighted index that includes all inflation-protected public obligations issued by the US Treasury with remaining maturities of less than 5 years. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the securities that make up the index, holding each security in approximately the same proportion as its weighting in the index.
Read more on VTIP →
